Works by Park, Cheol Kyu


Results: 46
    1

    Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.

    Published in:
    2018
    By:
    • In-Jae Oh;
    • Jae Young Hur;
    • Cheol-Kyu Park;
    • Young-Chul Kim;
    • Seung Joon Kim;
    • Min Ki Lee;
    • Hee Joung Kim;
    • Kye Young Lee;
    • Jae Cheol Lee;
    • Chang-Min Choi;
    • Oh, In-Jae;
    • Hur, Jae Young;
    • Park, Cheol-Kyu;
    • Kim, Young-Chul;
    • Kim, Seung Joon;
    • Lee, Min Ki;
    • Kim, Hee Joung;
    • Lee, Kye Young;
    • Lee, Jae Cheol;
    • Choi, Chang-Min
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7

    Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 112, doi. 10.4143/crt.2022.381
    By:
    • Jang Ho Lee;
    • Eun Young Kim;
    • Cheol-Kyu Park;
    • Shin Yup Lee;
    • Min Ki Lee;
    • Seong-Hoon Yoon;
    • Jeong Eun Lee;
    • Sang Hoon Lee;
    • Seung Joon Kim;
    • Sung Yong Lee;
    • Jun Hyeok Lim;
    • Tae-Won Jang;
    • Seung Hun Jang;
    • Kye Young Lee;
    • Seung Hyeun Lee;
    • Sei Hoon Yang;
    • Dong Won Park;
    • Chan Kwon Park;
    • Hye Seon Kang;
    • Chang Dong Yeo
    Publication type:
    Article
    8
    9
    10
    11

    Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 17, p. 5809, doi. 10.1002/cam4.4127
    By:
    • Kim, Taeyun;
    • Jang, Tae Won;
    • Choi, Chang Min;
    • Kim, Mi‐Hyun;
    • Lee, Sung Yong;
    • Park, Cheol‐Kyu;
    • Chang, Yoon Soo;
    • Lee, Kye Young;
    • Kim, Seung Joon;
    • Yang, Sei Hoon;
    • Ryu, Jeong Seon;
    • Lee, Jeong Eun;
    • Lee, Shin Yup;
    • Park, Chan Kwon;
    • Lee, Sang Hoon;
    • Jang, Seung Hun;
    • Yoon, Seong Hoon
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19

    Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea.

    Published in:
    Thoracic Cancer, 2024, v. 15, n. 6, p. 448, doi. 10.1111/1759-7714.15213
    By:
    • Jeon, Da Som;
    • Park, Cheol‐kyu;
    • Kim, Seung Joon;
    • Park, Chan Kwon;
    • Chang, Yoon Soo;
    • Jung, Chi Young;
    • Lee, Sung Yong;
    • Lee, Shin‐Yup;
    • Ryu, Jeong‐Seon;
    • Lee, Jeong Eun;
    • Lee, Kye Young;
    • Jang, Tae Won;
    • Jang, Seung Hun;
    • Yoon, Seong Hoon;
    • Lee, Sang Hoon;
    • Choi, Chang‐min;
    • Kim, Hyeong Ryul;
    • Kim, Yeon Joo
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46